MedPath

Pregnant Obese Women and Fetal Ultrasound Quality.

Not Applicable
Completed
Conditions
Obese Women
Pregnant Women
Interventions
Device: ultrasound propagation velocities, ultrasound fetal quality
Registration Number
NCT04212234
Lead Sponsor
University Hospital, Clermont-Ferrand
Brief Summary

Ultrasound (US) image construction uses equations that contain the value of the propagation velocity of sound waves; this velocity is assumed conventionally to be constant and equal to 1540 m/s in the human body. Since 1977, all manufacturers of US scanners have used this value, which was first established in 1950. In fatty tissue, however, the actual propagation velocity is only in the order of 1450 m/s. US velocity in fat tissue is slower than in other soft tissues (ie:1450 m/s vs 1540 m/s) therefore the intrinsic image quality in terms of sharpness and precision is improved when considering this parameter for image construction The main objective of this study is to evaluate the impact of ultrasound propagation velocity setting on completeness of ultrasound exams and images quality during the second and third trimester fetal ultrasound examination in obese patients.

Detailed Description

Obese pregnant women will be included before the second trimester fetal ultrasound examination.

Women will be allocated to one intervention group or to the control group. In the intervention group, the ultrasonographer will be able to use several ultrasound propagation velocities to perform the exam.

In the control group, exam will be performed using the conventional ultrasound velocity.

An exam will be considered to be complete if all the images recommended by national guideline are acquired. If ultrasound images are missing, other ultrasound exams may be performed until completeness is reached.

The protocol will be applied for the second and the third fetal ultrasound examination which are recommended by national guideline.

All scans will be evaluated by two independent experts who do not have performed any of the exams. They will evaluate the completeness of each exam. Each scan will be quoted using the quality score proposed by Salomon et al.

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
596
Inclusion Criteria
  • Body mass index>30
  • Between 20 and 25 weeks of gestation
Exclusion Criteria
  • Multiple pregnancy
  • Uterine scare

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
free ultrasound propagation velocityultrasound propagation velocities, ultrasound fetal qualityultrasound exams will be performed using several ultrasound propagation velocities
Primary Outcome Measures
NameTimeMethod
image quality of fetal ultrasound examsecond trimester and third trimester ultrasound exam

Quality will be assessed by calculating Salomon's score for each image.

completeness of fetal ultrasound examsecond trimester and third trimester ultrasound exam

completeness will be assessed by the number of the recommended images which could have been registered during the first ultrasound exam in each trimester.

Secondary Outcome Measures
NameTimeMethod
use of supplementary ultrasound exams in order to assess completenessthrough study completion, an average of 1 year

description of each modality of supplemental ultrasound exam

description of ultrasonographist method in order to improve ultrasound examthrough study completion, an average of 1 year

description of modality

economic analysis of the interventionthrough study completion, an average of 1 year

cost-effectiveness analysis

Trial Locations

Locations (5)

H么pital Estaing - Centre Hospitalier Universitaire de Clermont-Ferrand

馃嚝馃嚪

Clermont-Ferrand, France

H么pital de la Croix Rousse - Hospices Civils de Lyon

馃嚝馃嚪

Lyon, France

H么pital Femme M茅re Enfant - Hospices Civils de Lyon

馃嚝馃嚪

Lyon, France

H么pital Arnaud de Villeneuve - CHU de Montpellier

馃嚝馃嚪

Montpellier, France

H么pital Cochin - Assistance Publique - H么pitaux de Paris

馃嚝馃嚪

Paris, France

漏 Copyright 2025. All Rights Reserved by MedPath